Endeavour Invest in the media

Since 2009, Endeavour Invest has been a significant and central partner to Danish football club, FC Fredericia, through Monjasa as primary sponsor of the club. Following a successful capital increase, Multiple Holding has now acquired a majority stake in FC Fredericia, now holding 60.5% of the club’s share capital. The investment marks a significant milestone in the club’s development as it prepares for its debut season in the best Danish football league, Superliga. The capital expansion raised a total of DKK 17 million and reflects strong investor confidence in FC Fredericia’s long-term potential. The funding supports FC Fredericia’s continued growth, including infrastructure upgrades, organisational strengthening and sporting ambitions. “This investment reflects our support and belief in FC Fredericia’s long-term potential and the city’s vibrant future. We are proud to contribute to building a strong foundation for the club - both on the pitch and in the wider community. The club’s positive development underscores our commitment to actively promote community and culture locally,” says Anders Østergaard, Founder & CEO, Endeavour Invest. The capital increase also enables FC Fredericia to move forward with the planned expansion of Monjasa Park in collaboration with Fredericia Municipality. The stadium’s capacity will increase from 4.000 to...

Read More Multiple Holding becomes majority shareholder in FC Fredericia

Endeavour Invest shareholder company, Cell to Cure, has introduced a new corporate visual identity to support its continued development and evolving role within advanced cell-based therapies. A part of shaping future progress The updated identity includes a sweeping online and offline visual modernisation, including refreshed company logo and colour palette. The changes are interned to create a clearer and more consistent expression of the company’s scientific work, values and ambitions in their field. The new identity has been rolled out across all digital and physical touchpoints, reinforcing internal alignment and enhancing external visibility. While not a change in strategy, the visual update signals Cell to Cure’s continued commitment to advancing cell-based therapies and taking new steps in shaping the future of biotech innovation. About Cell to Cure Founded in 2018, Cell to Curespecialises in the development and manufacturing of allogenic mesenchymal stomal cell therapies derived from adipose tissue. These therapies are being explored for their potential to threat a range of inflammatory and degenerative diseases, including cardiovascular and autoimmune conditions.With a strong focus on clinical-grade production and scalability, the company aims to bring safe and effective cell therapies closer to the patients.

Read More Strengthening Cell to Cure’s brand clarity and visibility

Looking at the financial results, Endeavour Invest concluded 2024 with a revenue of USD 4.5bn (2023: 4.4bn) and a net result of USD 52m (2023: USD 113m), leading to an improved consolidated Group equity of USD 471m (2023: USD 437m). Focusing on Monjasa Holding A/S, we continued to see a strong demand for Monjasa’s services throughout the year, confirming the company’s ability to observe and navigate risks and opportunities around them while maintaining a strong focus on the core business. An important contributor to these financial results was led by Monjasa’s ability to respond positively to whatever challenges the day may bring. This is a true Monjasa strength and made possible by keeping a close eye on our overall cost base throughout the years. Another factor contributing positively to the 2024 financial performance was the continued investments in Monjasa’s global fleet and logistics and fully integrating these with the marine fuels activities. Investing in offshore wind logistics In 2024, we also invested further in offshore wind logistics as CBED took ownership of the two new sister CSOVs, Wind Evolution and Wind Creation, sending the total fleet size up from one to three vessels. With immediate market demand for both newcomers,...

Read More Endeavour Invest reports third-best financial year

60 million tickets sold worldwide. The second highest-grossing musical in Broadway history. Performances in over 100 cities worldwide and numerous awards. Several million albums sold of the original Broadway soundtrack and still one of the biggest hits on both Broadway, in the West End and in all other cities where it is performed. WICKED is the musical of records. In 2024, the musical could be experienced in Frederica, Denmark, when Fredericia Musicalteater in collaboration with AHA Creations, an Endeavour Invest company, was granted the rights to present a new spectacular version of the legendary musical about the witches of Oz. The performance premiered at both Fredericia Musicalteater and Copenhagen’s Tivoli Concert Hall in a co-production with Tivoli. WICKED nominated for the 2025 Reumert of the Year Director Thomas Agerholm's production of WICKED took both the audience and critics by storm, with several media giving it five- and six-star reviews. The Danish Politiken, gave the musical an impressive five stars and wrote: "The musical fully lives up to its name: It's wickedly good". Today, the extraordinarily critically acclaimed musical success WICKED, can boast a Reumert nomination for musical star Nanna Rossen, starring as one of the lead roles as Elphaba, in...

Read More Five-star reviews to AHA Creations’ WICKED musical

2024 became another positive year for global marine fuels supplier, Monjasa Holding A/S, an Endeavour Invest company. In fact, it was the third-strongest year ever when looking at the financial performance.The financial year was positively affected by a strong demand in both trading activities and across Monjasa’s own maritime logistics and supply chains. In particular, Monjasa continued to see a steady increase in demand from global customers, which includes the world’s largest shipowning companies benefiting from collaboration across Monjasa’s 16 international offices. Another important contributor to the 2024 financial performance was the continued investments in Monjasa’s global tanker fleet and fully integrating these into the marine fuels activities. With the purchases of an additional three tankers, Monjasa Hunter, Monjasa Rover and Monjasa Master, the Monjasa fleet concluded the year with a total of 33 owned and chartered vessels deployed worldwide. Monjasa Group CEO, Anders Østergaard: “We are satisfied with the achieved results and to record a 4% volume increase despite the overall global trade slow-down. This shows that Monjasa continues to deliver the right quality and that our personal service is in demand by shipowners.At a time where global trade confrontations and uncertainties are building up, we also take comfort in our stable customer base...

Read More Monjasa reports third-best financial year – Annual Report 2024

Fredericia Musicalteater and AHA Creations, in collaboration with Chief1 and the Danish “We Love” phenomenon, present a new original musical experience: WHAT IS LOVE - a We Love the 90’s musical. On September 20, 2025, the year's biggest 90’s party will come to Fredericia Musicalteater in the form of a new original musical, which pays tribute t o the biggest hits from the 90’s - the sound that defined a decade. “Pump up the Jam”, “Sing Hallelujah” and “What is Love” - the sound of the 90’s is bigger than ever before, and now nostalgic, party-loving, 90’s fans can get the ultimate total experience when WHAT IS LOVE moves to Fredericia Musicalteater. As the first of its kind, the musical delves into the 90’s music industry and tells the story of a time when young people started a music revolution and left their mark on the future. The performance will be a spectacular celebration of the biggest hits of the 90s and an opportunity to relive the golden age of music - with love for music and each other at the centre. More than a musical Audiences should prepare for a unique musical experience where the boundaries between stage and...

Read More A tribute to the 90’s: AHA Creations presents next musical

Led by Endeavour’s ownership of global marine fuels supplier, Monjasa, the company realised the second-best financial performance ever, which contributed to an all-time high consolidated equity of USD 437m. An important contributor to Monjasa’s solid financial performance, was the ability to navigate the high market volatility and determination to continue strengthening the fleet. Overall, the Monjasa fleet of owned tankers increased from 12 to 14 during 2023, while the total number of tankers and barges deployed worldwide remained steady at 30. Looking at the overall financial performance, Endeavour Invest concluded 2023 with revenue of USD 4.4bn (USD 5.5bn) and a net result of USD 113m (2022: USD 170m), which led to a significantly improved consolidated equity of USD 437m (2022: USD 327m).  Selling RelateIT to twoday Main developments in 2023 also included a farewell to a treasured Endeavour member, IT business unit, RelateIT. During August, we finalised the sale of all shares in RelateIT to Nordic IT Group, twoday. Under our ownership, RelateIT has grown to become a major player in Denmark within ERP solutions, with close to 200 colleagues working across six locations. Offshore developments Looking to the offshore wind industry, CBED, performed above expectations and demonstrated a strong...

Read More Endeavour Invest equity exceeds $400m following second-best financial year

In another year of high volatility across the global shipping markets, Monjasa Holding, an Endeavour Invest company, continued to experience an increase in total volume and realised the second-best financial performance ever, which led to an all-time high consolidated equity of USD 411m. In the marine fuels industry and across some of Monjasa’s core markets, this high volatility was felt through the changing maritime trade flows and operations. This was the case in the Americas where Monjasa successfully navigated the Panama Canal drought issues by providing new refuelling solutions to customers affected by the restricted number of transiting vessels. In the same way, towards the end of 2023, Monjasa adapted quickly and succeeded in matching supply and demand in West Africa, where the Red Sea security crisis caused a sudden spike in demand as container lines began rerouting millions of tonnes of cargo south of Africa via Cape of Good Hope.  Supplying a record volume of 6.5 million tonnes Monjasa concluded 2023 with a 2% increase in total volume which reached a record 6.5m metric tonnes (2022: 6.4m mts) of marine fuels supplied to shipowners and operators worldwide. With a net result of USD 109m (2022: USD 171m) the year...

Read More Monjasa equity exceeds $400m following second-best financial year – Annual Report 2023

Existing partner, Endeavour Cells ApS provides capital increase to Cell2Cure ApS and own thereby own 51% of the company. In collaboration with Endeavour Cells, the capital increase will be used to further develop Cell2Cure's stem cell products both technically, clinically and commercially. Cell2Cure's products will be made market-ready to promote treatment with stem cells within a number of diseases - both nationally and abroad. In addition to the capital injected, the collaboration with Endeavour Cells includes an agreement on milestone payments and possible continued financing of Cell2Cure's activities within a 5-year time frame. In connection with the capital increase, owner of Endeavour Cells ApS, Anders Østergaard, will become the new Chairman of the Board in Cell2Cure. Anders Østergaard, CEO Endeavour Invest: "We are convinced that stem cells in the long term will provide a significant contribution to the treatment of many different disorders and diseases. Endeavour Cells is therefore pleased to continue the collaboration and with the capital increase, we ensure Cell2Cure's is able to focus on the important and promising technical and clinical work in the coming years." Jens Kastrup, CEO & Clinical Director, Cell2Cure: "Cell2Cure is pleased with the trust that Endeavour Cells shows in our team and...

Read More Capital increase allows Cell2Cure to focus on further development of stem cell products

CBED expands fleet with two new SOVs: Wind Evolution and Wind Creation The Danish shipowning company, CBED, an Endeavour Invest ApS company specialised in tailor-made offshore accommodation solutions for the offshore energy sector, acquires two new vessels.  The two new SOVs, Wind Evolution and Wind Creation, are expected to be delivered end of Q1 2024 and join the CBED fleet which since 2008 have worked on 31 individual offshore wind projects in Northern Europe.   Following delivery from seller, Dutch-based shipping company Vroon, both Wind Evolution (formerly Vos Start) and Wind Creation (formerly Vos Stone) will be dry-docked for refurbishing, name change and painting according to the CBED fleet design. They will be ready to take on new walk-to-work, IRM and subsea projects starting Q2 2024. The parties have chosen not to disclose the sales amount.    Surge in demand for SOVs Looking to the future, the coming decade is likely to bring unprecedented demand for vessels to service projects in the offshore sector. According to Clarkson’s latest market report, the offshore wind sector alone is expecting 30,000 turbines and foundations are to be installed by 2030, and the yearly installation rate is set to double from 700-1,000 per year to more...

Read More Continuous Investment in Offshore Wind Logistics